MapLight Therapeutics officer proposes $93.8K sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. officer Erin Foff reported a proposed sale of 3,472 common shares, with an aggregate market value of $93,813.44 and an approximate sale date of April 15, 2026. The shares are to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit vesting. The securities table lists restricted stock unit grants from the issuer dated July 30, 2023, November 9, 2023, and May 2, 2024.
Key Figures
Key Terms
Restricted Stock Unit Grant financial
tax-withholding obligations financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When were the securities in Erin Foff's MPLT notice acquired?
AI-generated analysis. How Rhea-AI works. Not financial advice.